Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Rhabdomyosarcoma, Alveolar × TB-403 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Solid Tumors 1 Sarcoma, Ewing 1 Rhabdomyosarcoma, Alveolar 1 Recurrence 1 Ovarian Neoplasms 1 Neuroblastoma 1 Medulloblastoma 1 Glioblastoma 1 Colorectal Neoplasms 1 Carcinoma, Hepatocellular 1

Interventions

efineptakin alfa 1 TB-403 1 Crizotinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02748135 2021-01-13

A Study of TB-403 in Pediatric Subjects With Relapsed or Refractory Medulloblastoma

Oncurious NV

Phase 1 Completed

Medulloblastoma, Neuroblastoma, Recurrence, Sarcoma, Ewing, Rhabdomyosarcoma, Alveolar

Data powered by HemOnc (CC BY 4.0) Colophon ⚡